Among PD-1 inhibitors and PD-L1 inhibitors, the incidence of mild colitis is more frequent using PD-1 than PD-L1 (1.2% vs. 0.3%, respectively); for severe colitis, there is no significant difference between PD-1 and PD-L1 inhibitors [22]. The gene discussed is CD274; the disease is colitis.